193 related articles for article (PubMed ID: 31005623)
1. Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler.
Abadelah M; Chrystyn H; Larhrib H
Eur J Pharm Sci; 2019 Jun; 134():138-144. PubMed ID: 31005623
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
3. Study of the Emitted Dose After Two Separate Inhalations at Different Inhalation Flow Rates and Volumes and an Assessment of Aerodynamic Characteristics of Indacaterol Onbrez Breezhaler
Abadelah M; Chrystyn H; Bagherisadeghi G; Abdalla G; Larhrib H
AAPS PharmSciTech; 2018 Jan; 19(1):251-261. PubMed ID: 28695328
[TBL] [Abstract][Full Text] [Related]
4. Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler.
Abadelah M; Hazim F; Chrystyn H; Bagherisadeghi G; Rahmoune H; Larhrib H
Eur J Pharm Sci; 2017 Jun; 104():180-187. PubMed ID: 28351669
[TBL] [Abstract][Full Text] [Related]
5. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
[TBL] [Abstract][Full Text] [Related]
7. Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.
Chapman KR; Fogarty CM; Peckitt C; Lassen C; Jadayel D; Dederichs J; Dalvi M; Kramer B
Int J Chron Obstruct Pulmon Dis; 2011; 6():353-63. PubMed ID: 21760722
[TBL] [Abstract][Full Text] [Related]
8. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol.
Pavkov R; Mueller S; Fiebich K; Singh D; Stowasser F; Pignatelli G; Walter B; Ziegler D; Dalvi M; Dederichs J; Rietveld I
Curr Med Res Opin; 2010 Nov; 26(11):2527-33. PubMed ID: 20843166
[TBL] [Abstract][Full Text] [Related]
10.
Hamilton M; Anderson M; Dhand R; Patmore O; Prime D; Taylor E
J Aerosol Med Pulm Drug Deliv; 2023 Feb; 36(1):34-43. PubMed ID: 36695722
[No Abstract] [Full Text] [Related]
11. Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort
Bagherisadeghi G; Larhrib EH; Chrystyn H
Int J Pharm; 2017 Apr; 522(1-2):137-146. PubMed ID: 28254655
[TBL] [Abstract][Full Text] [Related]
12. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
[TBL] [Abstract][Full Text] [Related]
14. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
15. The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions.
Farkas Á; Tomisa G; Kugler S; Nagy A; Vaskó A; Kis E; Szénási G; Gálffy G; Horváth A
Int J Pharm X; 2023 Dec; 5():100167. PubMed ID: 36824288
[TBL] [Abstract][Full Text] [Related]
16. The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers.
Abadelah M; Al-Assadi J; Rooney J; Larhrib H
Saudi Pharm J; 2020 Jan; 28(1):74-86. PubMed ID: 31920434
[TBL] [Abstract][Full Text] [Related]
17. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
[TBL] [Abstract][Full Text] [Related]
18. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
Broeders ME; Molema J; Burnell PK; Folgering HT
J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
[TBL] [Abstract][Full Text] [Related]
19. Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection.
Farkas Á; Szipőcs A; Horváth A; Horváth I; Gálffy G; Varga J; Galambos K; Kugler S; Nagy A; Szalai Z
Respir Med; 2019; 154():133-140. PubMed ID: 31252206
[TBL] [Abstract][Full Text] [Related]
20. Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers.
Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):223-230. PubMed ID: 33147100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
